Zai Lab Ltd

ZLAB

Company Profile

  • Business description

    Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

  • Contact

    899 Halei Road
    Building B
    Pudong
    Shanghai201203
    CHN

    T: +86 2161632588

    E: [email protected]

    https://www.zailaboratory.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    1,844

Stocks News & Analysis

stocks

Does SpaceX’s sky-high valuation make sense?

SpaceX’s $1.5 trillion valuation looks expensive and risky, but not irrational.
stocks

ASX healthcare leader sees further cuts to fair value

Fiercer competition expected to squeeze margins.
stocks

Avoid this overpriced ASX share

This ASX share is 84% overvalued and lacks a sustainable competitive advantage.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,976.8020.700.23%
CAC 407,982.9310.56-0.13%
DAX 4023,588.79379.84-1.58%
Dow JONES (US)47,706.5134.29-0.07%
FTSE 10010,321.3990.85-0.87%
HKSE25,898.7661.14-0.24%
NASDAQ22,697.101.160.01%
Nikkei 22555,025.37776.981.43%
NZX 50 Index13,293.13198.761.52%
S&P 5006,781.480.000.00%
S&P/ASX 2008,743.5019.400.22%
SSE Composite Index4,133.4310.290.25%

Market Movers